These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 33132411)

  • 1. Open Innovation or Traditional Patenting Strategies to Efficiently Address Health Emergencies? How Patent Information Was Used Towards Effective Treatments for COVID-19.
    de Almeida TDME; Cordeiro DS
    Recent Pat Biotechnol; 2024 Jun; ():. PubMed ID: 38910270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic biology, patenting, health and global justice.
    van den Belt H
    Syst Synth Biol; 2013 Sep; 7(3):87-98. PubMed ID: 24432146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical research without patents: It's preferable, it's profitable, and it's practicable.
    Radder H; Smiers J
    Account Res; 2024 Mar; ():1-22. PubMed ID: 38450500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patenting: the Bayh-Dole Act and its transformative impact on science innovation and commercialization.
    Miteu GD
    Ann Med Surg (Lond); 2024 Jun; 86(6):3192-3195. PubMed ID: 38846872
    [No Abstract]   [Full Text] [Related]  

  • 5. Repurposing therapeutics for COVID-19: Rapid prediction of commercially available drugs through machine learning and docking.
    Mohapatra S; Nath P; Chatterjee M; Das N; Kalita D; Roy P; Satapathi S
    PLoS One; 2020; 15(11):e0241543. PubMed ID: 33180803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights from nanotechnology in COVID-19 treatment.
    Tang Z; Zhang X; Shu Y; Guo M; Zhang H; Tao W
    Nano Today; 2021 Feb; 36():101019. PubMed ID: 33178330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of probiotics in COVID-19 treatment: Gut microbiota can help physicians in the outbreak.
    Şahin M
    Turk J Gastroenterol; 2020 Oct; 31(10):724-725. PubMed ID: 33169711
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 update: The race to therapeutic development.
    Twomey JD; Luo S; Dean AQ; Bozza WP; Nalli A; Zhang B
    Drug Resist Updat; 2020 Dec; 53():100733. PubMed ID: 33161277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19: the epidemiology and treatment.
    Qu L; Li J; Ren H
    Br J Hosp Med (Lond); 2020 Oct; 81(10):1-9. PubMed ID: 33135928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocellulose, the Green Biopolymer Trending in Pharmaceuticals: A Patent Review.
    Garcia KR; Beck RCR; Brandalise RN; Dos Santos V; Koester LS
    Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38276515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How does social network in patent provide changes in the Chinese manufacturing firm market value?
    Luo K; Zor S
    Heliyon; 2023 Mar; 9(3):e14358. PubMed ID: 36942235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Launch sequencing of pharmaceuticals with multiple therapeutic indications: evidence from seven countries.
    Mills M; Michaeli D; Miracolo A; Kanavos P
    BMC Health Serv Res; 2023 Feb; 23(1):150. PubMed ID: 36782175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent and Marketing Exclusivities 101 for Drug Developers.
    Oronsky B; Caroen S; Brinkhaus F; Reid T; Stirn M; Kumar R
    Recent Pat Biotechnol; 2023; 17(3):257-270. PubMed ID: 36635930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategic Patenting by Pharmaceutical Companies - Should Competition Law Intervene?
    Gurgula O
    IIC Int Rev Ind Prop Copyr Law; 2020; 51(9):1062-1085. PubMed ID: 33132411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bib Pharma Monopoly: Why Consumers Keep Landing on "Park Place" and How the Game is Rigged.
    Levy MS
    Am Univ Law Rev; 2016; 66(1):247-303. PubMed ID: 28225582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling patenting strategies of therapeutics and vaccines: evergreening in the context of COVID-19 pandemic.
    Bacigalupo ML; Pignataro MF; Scopel CT; Kondratyuk S; Mellouk O; Chaves GC
    Front Med (Lausanne); 2023; 10():1287542. PubMed ID: 38126073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generic medicines: issues and relevance for global health.
    Rana P; Roy V
    Fundam Clin Pharmacol; 2015 Dec; 29(6):529-42. PubMed ID: 26405851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ownership of knowledge--the role of patents in pharmaceutical R&D.
    Correa CM
    Bull World Health Organ; 2004 Oct; 82(10):784-7; discussion 787-90. PubMed ID: 15643801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Competition and prices in the Mexican pharmaceutical market].
    Molina-Salazar RE; González-Marín E; Carbajal-de Nova C
    Salud Publica Mex; 2008; 50 Suppl 4():S496-503. PubMed ID: 19082261
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.